Sai Parenterals Ltd

Tue 17/11/2026,15:59:6 | NSE : SAIPARENT

₹496.55-9.85 (-1.95%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 510.00

Previous Close

₹ 506.40

Volume

162402

Mkt Cap ( ₹ Cr)

₹ 2193.72

High

₹ 514.90

Low

₹ 490.25

52 Week High

₹ 706.00

52 Week Low

₹ 400.00

Book Value Per Share

₹ 112.88

Dividend Yield

0.00

Face Value

₹ 5.00

What's Your Call?

Collective community sentiment on Sai Parenterals Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

496.55

2302

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

2302

Option Chain

Analyzes market sentiment, predicts Sai Parenterals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sai Parenterals to acquire majority stake in Bion Therapeutics’ Prescription Business

    17 Nov 2026, 10:25AM Sai Parenterals Limited, through its wholly owned subsidiary SP Analytics Private Limited, has signed a definitive agreement to acquire a majority sta
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    17 Nov 2026, 10:11AM Press Release by Sai Parenteral's Limited
  • Sai Parenterals - Outcome of Board Meeting

    16 Nov 2026, 9:22PM Sai Parenterals Limited has informed the Exchange regarding Outcome of Board Meeting held on November 16, 2026.
  • Sai Parenterals - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 16Th November, 2026

    16 Nov 2026, 9:05PM Outcome of Board Meeting held on Monday, 16th November, 2026
  • Sai Parenterals - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Nov 2026, 5:18PM Sai Parenterals Limited has informed the Exchange about Transcript
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    7 Nov 2026, 4:57PM call conducted on Monday the 2nd day of November, 2026.
  • Sai Parenterals - Copy of Newspaper Publication

    3 Nov 2026, 2:44PM Sai Parenterals Limited has informed the Exchange about Copy of Newspaper Publication of un-audited financial results for the quarter and half-year en
  • Sai Parenterals - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Nov 2026, 8:57PM Sai Parenterals Limited has informed the Exchange about Link of Recording
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    2 Nov 2026, 8:50PM Audio recording of earning call held on 2nd November, 2026 over call.
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Investor Presentation

    1 Nov 2026, 8:14PM Investor Presentation for the quarter and half year ended 30th September, 2026
  • Sai Parenterals - Investor Presentation

    1 Nov 2026, 8:10PM Sai Parenterals Limited has informed the Exchange about Investor Presentation
  • Sai Parenterals Q2 net profit up 15.07% at Rs 6.49 cr

    1 Nov 2026, 8:00PM The company reported standalone net profit of Rs 6.49 crore for the quarter ended September 30, 2026 as compared to Rs 5.64 crore in the same period l
  • Sai Parenterals - Press Release

    1 Nov 2026, 6:25PM Sai Parenterals Limited has informed the Exchange regarding a press release dated November 01, 2026, titled ""Press Release "".
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    1 Nov 2026, 6:18PM Investor press release on standalone and consolidated unaudited financial results for the quarter ended 30th September, 2026.
  • Sai Parenterals - Statement Of Variation And Deviation

    1 Nov 2026, 6:07PM Statement of variation and deviation for the period ended 30th September, 2026
  • Sai Parenterals - Statement of deviation(s) or variation(s) under Reg. 32

    1 Nov 2026, 6:00PM Sai Parenterals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Sai Parenterals - Addendum

    1 Nov 2026, 4:58PM Sai Parenterals Limited has informed the Exchange about Addendum
  • Sai Parenterals - Financial Results For The Quarter And Half-Year Ended 30Th September, 2026.

    1 Nov 2026, 4:05PM Financial Results
  • Sai Parenterals - Outcome of Board Meeting

    1 Nov 2026, 3:09PM Sai Parenterals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
  • Sai Parenterals - Unaudited Financial Results For The Quarter And Half-Year Ended September 30Th 2026.

    1 Nov 2026, 2:59PM Unaudited financial results for the quarter and half-year ended September, 30th 2026.
  • Sai Parenterals - Board Meeting Outcome for Outcome Of Board Meeting Held On 1St November, 2026

    1 Nov 2026, 2:52PM Outcome of Board Meeting held on 1st November, 2026
  • Sai Parenterals - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Oct 2026, 6:13PM Sai Parenterals Limited has informed the Exchange about Schedule of meet
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Oct 2026, 6:00PM Schedule of Q2 of FY 2026-27 Earnings Conference Call.
  • Sai Parenterals - Board Meeting Intimation for Declaration Of Unaudited Financial Results Of The Quarter And Half Year Ended

    27 Oct 2026, 10:45AM Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2026 ,inter alia, to consider and
  • Sai Parenterals has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    16 Oct 2026, 11:00AM As of September 2026, 51.16% is owned by Indian Promoters and 48.84% by Public. <p align=justify> Institutional holds 10.68% (Insurance Companies 2.35
  • Sai Parenterals - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Oct 2026, 2:20PM Sai Parenterals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Sai Parenterals - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2026, 2:10PM RTA's Certificate
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    5 Oct 2026, 3:42PM Media release about the acquisition.
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    3 Oct 2026, 12:00PM Monitoring agency report for the quarter ended 30 June 2026
  • Sai Parenterals - Press Release

    5 Oct 2026, 3:54PM Sai Parenterals Limited has informed the Exchange regarding a press release dated October 05, 2026, titled ""Sai Parenterals Completes the Acquisition
  • Sai Parenterals acquires 60% stake in Prathyak Laboratories for Rs 15 cr

    5 Oct 2026, 3:53PM Sai Parenterals Limited has completed the acquisition of a 60% equity stake in Prathyak Laboratories Private Limited, an operational research and deve
  • Sai Parenterals - Monitoring Agency Report

    3 Oct 2026, 12:10PM Monitoring agency report for the quarter ended 30 June 2026
  • Sai Parenterals - Analysts/Institutional Investor Meet/Con. Call Updates

    1 Oct 2026, 5:40PM Sai Parenterals Limited has informed the Exchange about Schedule of meet
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    1 Oct 2026, 5:27PM Intimation of Schedule of Analyst / Institutional Investor meetings under Regulation 30 (read with Para A of Part A of Schedule III) of SEBI (Listing
  • Sai Parenterals - Trading Window

    30 Sep 2026, 6:23PM Sai Parenterals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,
  • Sai Parenterals - Resignation of Director/KMP/SMP

    30 Sep 2026, 6:08PM Sai Parenterals Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Sai Parenterals - Change in Company Secretary/Compliance Officer

    30 Sep 2026, 12:13PM Sai Parenterals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
  • Sai Parenterals - Outcome of Board Meeting

    30 Sep 2026, 12:11PM Sai Parenterals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 30, 2026.
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Change in Management

    30 Sep 2026, 12:05PM Outcome of the Board Meeting
  • Sai Parenterals - Board Meeting Outcome for Board Meeting Appointment Of Mr.Ashwani Singh Bisht CS And Mr.Arvind As COO.

    30 Sep 2026, 12:01PM Board Meeting Appointment of Mr. Ashwani Singh Bisht CS and Mr. Arvind as COO.
  • Sai Parenterals - Shareholders meeting

    10 Sep 2026, 4:46PM Sai Parenterals Limited has informed the Exchange about Shareholders meeting
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Outcome of AGM

    10 Sep 2026, 4:37PM Outcome of 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    10 Sep 2026, 4:40PM Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.
  • Sai Parenterals Q1 net profit zooms 969.88% at Rs 8.88 cr

    26 Aug 2026, 6:00PM The company reported standalone net profit of Rs 8.88 crore for the quarter ended June 30, 2026 as compared to Rs 0.83 crore in the same period last y
  • Sai Parenterals - Press Release

    25 Aug 2026, 6:45PM Sai Parenterals Limited has informed the Exchange regarding a press release dated August 25, 2026, titled ""Announcement under Regulation 30 (LODR)"".
  • Sai Parenterals - Bagging/Receiving of orders/contracts

    25 Aug 2026, 6:42PM Sai Parenterals Limited has informed the Exchange about Bagging/Receiving of orders/contracts
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 Aug 2026, 6:39PM Announcement under Regulation 30 (LODR)
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    25 Aug 2026, 6:36PM Announcement under Regulation 30 (LODR)
  • Sai Parenterals - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Aug 2026, 5:43PM Sai Parenterals Limited has informed the Exchange about Schedule of meet
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    25 Aug 2026, 5:19PM Intimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August, 2026
  • Sai Parenterals - Copy of Newspaper Publication

    20 Aug 2026, 2:49PM Intimation-Newspaper Publication of Notice of 25"" Annual General Meeting of the Company for the financial year 2025-26.
  • Sai Parenterals - Copy of Newspaper Publication

    20 Aug 2026, 2:45PM Submission of Newspaper Publication(s) in PAS-1 for change and variation in the objects of utilization of the Initial Public Offering ( IPO ) proceeds
  • Sai Parenterals - Book Closure Intimation For 25Th Annual General Meeting

    19 Aug 2026, 6:00PM Book closure intimation for 25th Annual General Meeting
  • Sai Parenterals - Reg. 34 (1) Annual Report.

    19 Aug 2026, 5:58PM Annual Report of the company for FY 2025-26
  • Sai Parenterals - General Updates

    19 Aug 2026, 5:58PM Sai Parenterals Limited has informed the Exchange about Intimation of Book closure and cutoff date for the 25th Annual General Meeting
  • Sai Parenterals - Shareholders meeting

    19 Aug 2026, 5:51PM Sai Parenterals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 10, 2026
  • Sai Parenterals - Notice Of 25Th Annual General Meeting

    19 Aug 2026, 5:49PM Notice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September, 2026.
  • Sai Parenterals - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Aug 2026, 12:34PM Sai Parenterals Limited has informed the Exchange about Transcript
  • Sai Parenterals - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    18 Aug 2026, 12:30PM Transcript of Earnings Call held on 12th August, 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.
  • Sai Parenterals Ltd

    17 Nov 2026 , 9:57AM Sai Parenterals : The company, through its wholly owned subsidiary SP Analytics, will acquire a majority stake in Hyderabad-based Bion Therapeutics India, a branded prescription formulations business.Upon completion of the transaction, which is expected before the end of this month, Bion Therapeutics India will become a step-down subsidiary of Sai Parenterals. The transaction will be an all-cash deal.
  • Sai Parenterals Ltd

    2 Jul 2026 , 9:51AM Sai Parenterals: The company's Australian subsidiary, Noumed Pharmaceuticals, has renewed its long-term exclusive OTC Medicines Supply Agreement with Australia's multi-billion-dollar pharmacy chain. The renewed agreement features an expanded product portfolio, a longer tenure, and a significantly higher contract value. The renewed agreement is valued at AUD 202 million (~ Rs. 1,300 crore) over an extended tenure of seven and a half years, translating to about AUD27mn per annum. The agreement also includes an option for a further three-year extension upon mutual consent.

Key fundamentals

Evaluate the intrinsic value of Sai Parenterals Ltd stock 

Name March-26 March-25 March-23
Assets 620.19 163.011 100.0247
Liabilities 620.19 163.011 100.0247
Equity 22.09 13.309 7.1506
Gross Profit 30.581 26.854 17.6702
Net Profit 16.777 10.283 4.5844
Cash From Operating Activities 111.544 18.683 -20.8287
NPM(%) 10.34 8.27 4.73
Revenue 162.252 124.269 96.796
Expenses 131.671 97.415 79.1258
ROE(%) 3.36 2.06 0.91

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sai Parenterals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 768.70 -1.31 15.26 284.48 -26.19 0.65
Lotus Eye Hospital and Institute Ltd 104.96 3.73 477.09 1036.59 0.39 0.00
Vaishali Pharma Ltd 7.18 2.28 18.41 6502.88 15.42 0.00
Astec Lifesciences Ltd 556.30 0.52 0.00 1110.65 -363.14 0.00

Company Info

Our Company was originally incorporated as `Sai Parenteral's Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 12, 2001, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, our Company was converted into a public limited company pursuant to resolution of our Board dated December 24, 2021 and a special resolution of our Shareholders dated January 05, 2022, and consequently, the name of our Company was changed to `Sai Parenteral's Limited' and a fresh certificate of incorporation consequent upon conversion to public limited company dated January 17, 2022, was issued to our Company by the RoC.Major Events and Milestones:2001- Company was incorporated as a Private Limited Company under the name of Sai Parenteral's Private Limited.2016- Change in the ownership of the Company, due to acquisition of Equity Shares by our Promoters from the erstwhile promoters of the Company.- Acquired Unit-I and Unit-II.2021- Launch of Prefilled technology equipment in Unit-I.2022- Acquired Unit III and related business from Reichindia Pharma Limited. For details see "Acquisition of Business undertaking of Reichindia Pharma Limited on a slump sale basis" on page 270.- Acquired Unit IV and related business from Medreich Limited. For details see "Acquisition of Business undertaking of Medreich Limited on a slump sale basis" on page 271.2023- Incorporated, SP Analytics Private Limited one of our Subsidiary- Our Company achieved a turnover of ? 1,000 million2024- Our Company acquired 100 % shareholding of Revat Laboratories Private Limited, pursuant to which it became a wholly owned subsidiary of our Company.2025- Incorporated a wholly owned subsidiary, Sai Parenterals Pte. Limited in Singapore.- Acquisition of foreign step-down subsidiaries, Noumed Pharmaceuticals Pty Limited in Australia and Noumed Pharmaceuticals Limited in New Zealand.

Our Company was originally incorporated as `Sai Parenteral's Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 12, 2001, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, our Company was converted into a public limited company pursuant to resolution of our Board dated December 24, 2021 and a special resolution of our Shareholders dated January 05, 2022, and consequently, the name of our Company was changed to `Sai Parenteral's Limited' and a fresh certificate of incorporation consequent upon conversion to public limited company dated January 17, 2022, was issued to our Company by the RoC.Major Events and Milestones:2001- Company was incorporated as a Private Limited Company under the name of Sai Parenteral's Private Limited.2016- Change in the ownership of the Company, due to acquisition of Equity Shares by our Promoters from the erstwhile promoters of the Company.- Acquired Unit-I and Unit-II.2021- Launch of Prefilled technology equipment in Unit-I.2022- Acquired Unit III and related business from Reichindia Pharma Limited. For details see "Acquisition of Business undertaking of Reichindia Pharma Limited on a slump sale basis" on page 270.- Acquired Unit IV and related business from Medreich Limited. For details see "Acquisition of Business undertaking of Medreich Limited on a slump sale basis" on page 271.2023- Incorporated, SP Analytics Private Limited one of our Subsidiary- Our Company achieved a turnover of ? 1,000 million2024- Our Company acquired 100 % shareholding of Revat Laboratories Private Limited, pursuant to which it became a wholly owned subsidiary of our Company.2025- Incorporated a wholly owned subsidiary, Sai Parenterals Pte. Limited in Singapore.- Acquisition of foreign step-down subsidiaries, Noumed Pharmaceuticals Pty Limited in Australia and Noumed Pharmaceuticals Limited in New Zealand.

Parent Organisation

Sai Parenterals Ltd.

Founded

12/01/2021

Managing Director

Mr.Anil Kumar Karusala

NSE Symbol

SAIPARENTEQ

FAQ